Select Page

A top-5 pharmaceutical company sought to understand differentiating features of competitor COVID-19 vaccine programs and forecast regional market scenarios and commercial implications.

Shift Health examined the technical and clinical merits, supply and deployment feasibility, and access and adoption potential of competitor vaccines, complementing our insights with the perspectives of subject matter experts from across the globe. We convened and facilitated workshops involving global, cross-functional teams to align the organization on the differentiating aspects of their COVID-19 vaccine candidate and the likely market scenarios that commercial and access teams will face upon launch.

Our findings equipped global and regional teams with a nuanced understanding of the landscape and the key technical, logistical and market insights that will influence clinical, commercial and access planning.